作者
Ofri Mosenzon, Abdullah Alguwaihes, Jose Luis Arenas Leon, Fahri Bayram, Patrice Darmon, Timothy ME Davis, Guillermo Dieuzeide, Kirsten T Eriksen, Tianpei Hong, Margit S Kaltoft, Csaba Lengyel, Nicolai A Rhee, Giuseppina T Russo, Shinichiro Shirabe, Katerina Urbancova, Sergio Vencio, CAPTURE Study Investigators
发表日期
2021/12
期刊
Cardiovascular Diabetology
卷号
20
页码范围
1-13
出版商
BioMed Central
简介
Background
There is a paucity of global data on cardiovascular disease (CVD) prevalence in people with type 2 diabetes (T2D). The primary objective of the CAPTURE study was to estimate the prevalence of established CVD and its management in adults with T2D across 13 countries from five continents. Additional objectives were to further characterize the study sample regarding demographics, clinical parameters and medication usage, with particular reference to blood glucose-lowering agents (GLAs: glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors) with demonstrated cardiovascular benefit in randomized intervention trials.
Methods
Data were collected from adults with T2D managed in primary or specialist care in Australia, China, Japan, Czech Republic, France, Hungary, Italy, Argentina, Brazil, Mexico …
学术搜索中的文章
O Mosenzon, A Alguwaihes, JLA Leon, F Bayram… - Cardiovascular Diabetology, 2021